Biomedical Research in Developing Countries - UNICRI
Biomedical Research in Developing Countries - UNICRI
Biomedical Research in Developing Countries - UNICRI
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Bill and Mel<strong>in</strong>da Gates Foundation<br />
Global Health Program<br />
The Foundation was established <strong>in</strong> 1994 as the William H. Gates Foundation, and<br />
renamed as Bill and Mel<strong>in</strong>da Gates Foundation <strong>in</strong> 1999. The <strong>in</strong>stitution aims to<br />
globally improve healthcare and reduce poverty and, <strong>in</strong> the USA, to <strong>in</strong>crease<br />
educational opportunities and access to <strong>in</strong>formation technology. Its programmes<br />
are subdivided <strong>in</strong>to four ma<strong>in</strong> areas: Global Health, Poverty and Development,<br />
Education and Information, Special Programmes.<br />
The Global Health Program of the Bill and Mel<strong>in</strong>da Gates Foundation, comprises: the<br />
Global Alliance for Vacc<strong>in</strong>e and Immunization, the Institute for One World Health,<br />
the Children’s Vacc<strong>in</strong>e Programme, the University of Wash<strong>in</strong>gton Department of<br />
Global Health, HIV <strong>Research</strong>, Areas Global TB Vacc<strong>in</strong>e Foundation. The ma<strong>in</strong><br />
purpose of the Bill and Mel<strong>in</strong>da Gates Foundation Global Health Program is to allow<br />
advances <strong>in</strong> health to reach those populations that need them most, <strong>in</strong> particular<br />
people liv<strong>in</strong>g <strong>in</strong> poorest countries. The two ma<strong>in</strong> pr<strong>in</strong>ciples of its strategy are:<br />
accelerat<strong>in</strong>g access to health <strong>in</strong>terventions and new technologies; aupport<strong>in</strong>g<br />
research of new vacc<strong>in</strong>es, drugs and other health tools, with a primary <strong>in</strong>terest <strong>in</strong><br />
neglected diseases and <strong>in</strong> those issues affect<strong>in</strong>g primarily poor countries (malaria,<br />
tuberculosis, HIV/AIDS, nutrition problems, acute diarrheas illness, immunization,<br />
acute lower respiratory <strong>in</strong>fections, reproductive and maternal health, newborn and<br />
child health, other <strong>in</strong>fectious diseases).<br />
The Foundation is engaged <strong>in</strong> support<strong>in</strong>g efforts to build awareness of global health<br />
issues, develop<strong>in</strong>g documents and scientific material. The Bill and Mel<strong>in</strong>da Gates<br />
Foundation tries also to help lead<strong>in</strong>g relief organizations to respond appropriately to<br />
disasters which require special <strong>in</strong>terventions.<br />
http://www.gatesfoundation.org/Pages/home.aspx<br />
Brocher Foundation<br />
The Brocher Foundation started its works <strong>in</strong> 2003, by <strong>in</strong>itiative of Dr. Jaques E.W.<br />
Brocher and his wife. It was created as a private non-profit foundation of public<br />
<strong>in</strong>terest. The ma<strong>in</strong> goals of this Swiss private law foundation are: to permit to<br />
scientific researchers to have a place to work and to hold scientific meet<strong>in</strong>gs,<br />
encourag<strong>in</strong>g <strong>in</strong>terdiscipl<strong>in</strong>ary activities and connections among ethics, law and<br />
medic<strong>in</strong>e and <strong>in</strong>vestigat<strong>in</strong>g the implications of the development of research and new<br />
technologies. Its role <strong>in</strong> society is to be and communicate as an <strong>in</strong>terface by<br />
address<strong>in</strong>g public <strong>in</strong>stances, academic world, organizations and media.<br />
The ma<strong>in</strong> programmes of the Brocher Foundation are concentrated <strong>in</strong> the ethical,<br />
legal and societal implications of biotechnologies for human be<strong>in</strong>gs and their<br />
65